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Objectives. We compared the QRS waveforms of the initial and 
subsequent complexes of spontaneous ustained monomorphic 
ventrieular tachycardia nd the rhythm induced at dectrophysi- 
ologie study to test the theory that premature ventricular com- 
plexes "trigger" spontaneous ventricular tachycardia nd that a 
stable substrate xists such that the spontaneous arrhythmia can 
be reproduced at electrophysiologic study. 
Background. Failure rates have been high in several recent 
studies in which prevention of ventricular tachyarrhythmias was 
guided by suppression of premature ventricular complexes or 
induced ventricular tachycardias. 
Methods. Digital waveform analysis was used to distinguish events 
of ventricular tachycardia initiated by ¢onligurationally distinct, 
possibly triggering, complexes (type 1) I~rom events in which the 
initial QRS waveforms were identical to subsequent complexes, 
suggesting no requirement for premature ventricular beats (type 2). 
Results. Of 1,102 episodes of spontaneous ventricular tachy. 
¢ardia, 73 (6.6%) were type I; 1,012 were type 2 (91.8%); and 
17 (1.5%) were uncertain. Of 59 patients only 14 (24%) had only 
type I episodes (group 1), whereas 37 patients (63%) had predom. 
inantly type 2 events (grout~ 2) (p < 0.0001). Sustained ventricular 
tachycardia was inducible in all group 1 patients, and in most 
(57%) the induced rhythm was similar to the spontaneous rhythm. 
Ventricular tachycardia could not be induced in 7 patients from 
group 2 (19%), and in 18 patients (49%) the induced and 
spontaneous rhythms were dissimilar. Recurrence of arrhythmia 
rates differed according to the guidance method in group 2. 
Conclusions. Discrepancies between observed and predicted 
modes of initiation of ventricular tachycardia nd between spon- 
taneous and induced rhythms could result in inappropriate 
guidance and subsequent failure of antiarrhythmic treatment. 
(J Am Coil Cardio11995;26:489-96) 
The observation that a single stimulus can initiate ventricular 
fibrillation (1,2) led early investigators topropose that ventric- 
ular tachyarrhythmias and sudden death result from an appro- 
priately timed premature ventricular complex in patients with 
myocardial damage (3). Clinical observations appeared to 
support he "premature ventricular complex-trigger" hypoth- 
esis (4). The discovery that electrically induced premature 
beats were capable of initiating sustained monomorphic ven- 
tricular tachycardia n patients prone to this arrhythmia not 
only bolstered the premature ventricular complex-trigger hy- 
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pothesis, but also promoted the idea that pathologic changes in 
the myocardium produce a substrate that is stable over time 
(5,6). An extension of the premature ventricular complex- 
trigger-substrate model was the proposition that arrhythmias 
and sudden death could be prevented by drugs that eliminated 
premature ventricular complex triggers or disabled the sub- 
strate. Although early clinical studies appeared to confirm this 
paradigm (%10), several recent clinical trials have not (11-13). 
In particular, the arrhythmia recurrence rate in the Electro- 
physiologic Study Versus Electrocardiographic Monitoring 
(ESVEM) trial was high (37%, 41% and 66% at 1, 2 and 4 
years, respect'rely) despite treatment with antiarrhythmic 
drug,., predicted to be effective by one of the two management 
limb.,. (substrate suppression assessed by electrophysiologic 
study and trigger suppression assessed by Holter monitoring) 
(14-16). In addition, the performance of electrophysiologic 
studies appeared to be worse than in previous retrospective 
studies (17,18) and in some recent clinical trials (19,20). 
"lhe unsatisfactory response to treatment suggests a flaw in 
the anderlying concept, but it does not necessarily refute the 
preraature ventricular complex-trigger-substrate theory itself. 
Certainly, for instance, the excessive deaths in the Cardiac 
Arr!aythmia Suppression trial (11) and the high arrhythmia 
recurrence rate in the ESVEM trial (16) could have resulted 
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from toxicity of the antiarrhythmic drugs elected for the trials. 
However, assessments of outcome do not indicate where the 
breakdown occurs in the large number of steps and assump- 
tions between the basic model and the effect of treatment. The 
examination of spontaneous events permits more direct eval- 
uation of the premature v ntricular complex-trigger-substrate 
model. In the present investigation we analyzed the onset of 
sustained monomorphic ventricular taehyeardia in the absence 
of antiarrhythmic drugs to determine whether premature 
ventricular complexes were required for its initiation and 
whether tachyeardia induced at electrophysiologic study repro- 
duced the spontaneous arrhythmia. 
Methods 
Study patients, The Holter monitor tapes were obtained in 
the course of the ESVEM trial, which has been described in 
detail (14-16). Patients considered for this trial had to have a 
history of cardiac arrest, documented ventricular fibrillation, 
sustained ventricular tachycardia or syncope. Patients with 
recent myocardial infarction, the long QT syndrome, hypertr~: 
phic cardiomyopathy or arrhythmias caused by transient or 
reversible disorders were excluded. Enrolled patients had at 
least 10 premature ventricular complexesha and inducible, 
sustained ventricular tachyarrhythmias and were randomized 
to one of the two methods of guiding therapy: electrophysi- 
dogie studies or Holter monitoring. Antiarrhythmic drugs 
were then administered and tested, and their long-term efficacy 
was assessed (14). 
Analysis of recordings. The Holter recordings were ob- 
tained at least five half-lives after the discontinuation f all 
antiarrhythmic drugs except digitalis or drugs, such as bcta- 
adrenergic blocking agents and calcium channel blocking 
agents, when required for conditions other than ventricalar 
arrhythmias. Baseline Holter monitor ecordings (1,646 tapes) 
were obtained in 868 of the 2,103 patients screened for the trial 
(15). The tapes were analyzed and verified as described 
previously (14). Tapes with episodes of ventrieular tachycardia 
>-30 s were selected for further analyeis. Both char'~els were 
digitized at 100 Hz with 12-hit resolution and displayed at high 
resolution on a moniter. QRS complexes were individually 
windowed and the waveforms compared as previously de- 
scribed (21). Briefly, the first temporal derivatives of the 
signals were computed by fitting the samples to a five-point 
second-order function (22), and the waveforms were aligned by 
maxim~ing the cross-correlation function between the two 
QRS complex configurations. Because QRS complex configu- 
ration reflects an electrical~ activation sequence, a high corre- 
lation coefficient (r -> 0.90) between two complexes indicates a
common site of origin, whereas a low value (r < 0.80) suggests 
distinct sites of origin (21,23,24). Possible exceptions are 
discussed subsequently. 
Spentaneous, ustained monomorphic ventricular tachy- 
cardia was defined as a consecutive series of complexes of 
ventricular o igin with identical configuration (r >- 0.90), a rate 
>100 l~eats/min and a duration >--30 s. Type 1 vent~.,lar 
tachycardia was defined as an episode of spontaneous ventric- 
ular tachycardia preceded by >-1 premature beats with config- 
urations different from those of ventricular tachycardia, that is, 
r < 0.80 (Fig. IA). Type 2 ventricular tachycardia denoted an 
episode of spontaneous ventricular tachycardia n which the 
initial premature beat had a configuration identical to subse- 
quent ventricnlar tachycardia beats, that is, r >- 0.90 (Fig. 1B). 
The selection of the correlation coefficient cut points were 
based on our experie.nce omparing the QRS complex config- 
urations of premature ventricular complexes and ventricular 
tachycardia using 12-, 6- and 2-lead systems (21). Episodes in 
which the correlation between the initial premature beat and 
subsequent ventricular tachyeardia beats was between r < 0.90 
and r >- 0.80 were designated as uncertain (type U). Tnis 
"buffer zone" not only reduced the chance of including mis- 
classified events in the types 1 and 2 categories, but also 
allowed an assessment of the impact of the correlation coeffi- 
cient end points, because adding the type U events to the type 
1 group was equivalent to extending the type 1 threshold to r < 
0.90, and adding the type U events to the type 2 group was 
equivalent to extending the type 2 threshold to r -> 0.80. 
A type 1 event was considered a possible instance of 
triggering of ventricular tachycardia bypremature beats from a 
site of origin different from that of the ventricular tachycardia. 
Classically, apremature beat precipitates reentry into a region 
susceptible to slow conduction, heterogeneous repolarization 
and unidirectional block (23), although initiation of triggered 
zctivity is also possible (26). In type 2 ventricular tachyeardia, 
the identical configurations of the initial and subsequent 
heartbeats indicated acommon origin and an instance in which 
a manifest premature beat did not trigger the arrhythmia 
(27,28). A possible xception would be a premature v ntricular 
complex arising close to the site of exit of excitation due to 
ventricular tachycardia. Previous work (21) indicates that such 
premature ventricular complexes occur infrequently. Another 
possible exception would be if the first ventricular tachycardia 
complex were aberrantly conducted. This is unlikely because 
1) if the first ventricular tachycardia complex traverses an area 
of slow conduction it is more likely to arise later in the cycle, 
and 2) it has been shown using premature electrical stimuli that 
aberration of premature ventricular complex usually occurs 
only with very short coupling intervals (23), whereas we 
observed only one initial complex with a coupling interval 
<300 ms. A misclassification could occur when a complex of 
the same origin as ventricular tachycardia occurs o late in the 
preceding cycle that it fuses with the QRS complex of the next 
sinus beat. An impulse occurring so late in the cycle would be 
unlikely to trigger ventricular tachycardia, but the altered 
configuration of the fusion complex would result in a designa- 
tion as a type 1 event if not corrected. Such heartbeats were 
designated type 2f (for "fusion") and were easily distinguished 
by their timing, the presence of a preceding P wave and a 
waveform intermediate between the conducted QRS and 
ventricular tachycardia QRS (Fig. IC). 
Spontaneous ventricular tachycardia was recorded using 
two bipolar leads with body surface locations as specified in 
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Figure 1. Initiation of spontaneous sustained monomorphic 
ventricular tachyeardia (SMVT). A, Type t ventricular tachy- 
cardia. Normally conducted complexes (N) are interrupted by 
a premature v ntricular complex (P0 followed by ventrieular 
tachycardia complexes (Tt, I"2, T3). The correlation coefficient 
between Pj and T l is r = 0.73. B, Type 2 ventricular 
tachycardia. The initial ventricular complex of this episode is 
identical to subsequent ventricular tachycardia complexes 
(r = 0.97). C, Type 2fventricular tachyeardia. The last normal 
complex isfollowed by a ORS complex (F), which follows the 
P wave and has features of both normal and subsequent 
ventricular tachycardia complexes, indicating fusion. Fusion 
accounts for ~he low correlation coefficient (r = 0.76). 
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the trial protocol (14), whereas conventional electrocardio- 
graphic (ECG) leads were used at the time of electrophysi- 
ologic study to record induced ventricular tachycardia. There- 
fore, an exact comparison of the configurations of spontaneous 
and induced ventricular tachycardia wa~:~ot possible. For this 
reason, spontaneous and induced ventricular tachycardias 
were considered to be possibly identical if both had a fight 
bundle branch block pattern or both had a left bundle branch 
pattern as assessed from the configuration of the V l ECG lead 
and the corresponding Holter lead (29,30) and the cycle 
lengths differed by <80 ms. Otherwise, the two rhythms were 
considered to have dissimilm" sources. In previous tudies the 
rates of spontaneous and induced ventricular tachycardias 
have been identical (7,8), and in systematic comparisons of 
inducible ventricular tachycardia, differences incycle lengths of 
up to 10% (2 c') or 40 ms (31) have been permitted for rhythms 
to be considered to have identical origins. The 80-ms threshold 
(20% difference at a cycle length of 400 ms) was therefore a
relatively generous criterion, which favored the "possibly iden- 
tical" category. 
Programmed stimulation. There were eight levels of pro- 
grammed electrical stimulation (14). The first four were per- 
formed with the electrode catheter at the right ventricular 
ape):: 1) S z (a single premature ventficular extrastimulus 
during sinus rhythm); 2) SzS3 (two ventricular extrastimuli 
during sinus rhythm), 3) SiS2 (a train of eight ventricular 
stimuli at a constant cycle length followed by a single prema- 
ture ventficular extras.imulus); and 4) SlS2S 3 (a train of eight 
folk)wed by two extrastimuli). The next three levels were 
performed with the catheter at the right ventricular outflow 
tract: 5) StSz; 6) S1SES3; and 7) SISzS3S4 (a train of eight 
followed by three extrastimuli). The last level was performed at 
the right ventricular apex: 8) StSzS3S4. Each train of stimuli 
($1) was delivered at cycle lengths of 600, 500 and 400 ms. For 
the calculation of the mean cycle lengths, the sinus cycle length 
was assumed to be 700 ms to avoid excessive weighting of the 
mean values, but because a nonparametric test was used, this 
assumption did not affect the statistical comparison. The 
coupling interval of each extrastimulus ($2, $3, $4) was deliv- 
ered with an initial coupling interval of 400 ms and was 
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reduced by 10-ms decrements tothe point of refractoriness. An 
extrastimulus that was followed by another extrastimulus was 
placed 10 ms outside the refractory period of the previous 
ventricular beat, while the coupling interval of the later 
extrastimulus was reduced. The levels of stimulation were 
performed in order until a sustained ventricular tachyarrhyth- 
mia was induced twice or until all eight levels were completed 
(14). As previously described, the above protocol was also used 
to assess inducibility after initiation of antiarrhythmie drug 
therapy, except hat if the baseline arrhythmia required two or 
less extrastimuli for induction, then no more than two extra- 
stimuli were used in the follow-up study (14). 
Statistical analysis. The Shapiro-Wilk W test was used to 
test for normality. The statistical significance of differences 
between means of continuous variables was assessed by anal- 
ysis of variance when the distributions were normal and by the 
Wilcoxon rank-sum/Kruskal-Wailis test when the distributions 
were not normal. Logarithms of some variables, such as pre- 
mature ventricular complex frequencies, were used to obtain a 
normal distribution. Categorical variables were compared us- 
ing the likelihood ratio test. Actuarial analyses were performed 
for arrhythmia recurrence (sudden death, documented ventric- 
u!,lr tachycardia ~-15 beats in duration or unmonitored syn- 
cope) (14), sudden death and death from any cause. In the 
actuarial analyses of survival, patients were censored at the 
time of nonfatal arrhythmia recurrence because the study 
medication was usually discontinued following such an event. 
Data were plotted using the lifetable method of Kaplan and 
Meier (32) and compared using the log-rank test (33-35). A 
probability p < 0.05 was considered significant. 
Results 
Classification of ventficular tachycardia events. There 
were 1,102 episodes of spontaneous, sustained monomorphie 
ventricular tachycardia n the 59 Holter recordings. The mean 
(+SD) duration was 13.9 + 76.6 min (median was 78 s, range 
30 s to 16.4 h; mean cycle length was 391 +_ 78 ms (range 220 
to 571). Only 73 of the episodes (7%) were of type I onset. Of 
these, 37 (51%) were preceded by a single premature ventric- 
ular complex of differing ct, nfiguration (Fig. 1A), and 22 (30%) 
were preceded by two or more ventricular complexes with 
configurations different from ventricular tachycardia. The ob- 
servation that 14 t3qae 1 events (19%) were associated with 
premature supraventricular complexes indicated that a ventric- 
ular origin of the premature beat was not always required, and 
the finding that in some patients both supraventricular nd 
ventricular complexes preceded ventricular tachyeardia sug- 
gested that the site of origin of the ventricular complexes was 
not necessarily a critical factor for initiation of ventricular 
tachyeardia. 
The majority of ventricular tachycardia events (1,~'~12 
[92%]) were of type 2 onset (see Fig. 1B). Of these, 55 (6%) 
involved a fusion complex (Fig. 1C). There was no significant 
difference in the mean durations of type 1 (17 _+ 62 rain) and 
type 2 events (14 _+ 85 rain), but the mean cycle length of type 
1 events (367 -+ 73 ms) was significantly shorter than that of 
type 2 events (407 _+ 78 ms, p = 0.0005). There were only 17 
type U events (1.5%). The results did not significantly change 
by including all of the type U events with either the type 1 or 
type 2 groups. 
Analysis of longest episodes ofventr~cular tachycardia. To 
avoid excessive weighting of characteristics due to large num- 
bers of episodes in certain patients we also examined the 
longest ventricular tachycardia episode in each patient. In this 
group of 59 episodes, 17 were type 1, 37 were type 2 and 5 were 
type U. The mean duration of the type i ventricular tachycar- 
dia events (34 _.* 9 min) did not differ significantly from that of 
type 2 events (43.3 _+ 162 rain, p = 0.28), but the mean cycle 
length of the type 1 events (333 _+ 77 ms) was shorter than that 
of type 2 events (373 +_ 81 ms, p = 0.048). 
Premature beats that trigger reentry tend to have short 
coupling intervals because arlier impulses are more likely to 
encounter egions with incomplete repolarization and are 
more likely to cause slow conduction, which may be required 
for reentry (25). Therefore, differences in the timing of the 
initial heartbeats of tachycardia were expected between type 1 
and type 2 events. Indexes of prematurity were significantly 
lower for the premature beats of type 1 events than for the 
initial complexes of type 2 events, including the mean coupling 
interval (423 + 65 ms for type 1, 510 +_ 128 for type 2, p = 
0.02), the mean ratio of the coupling interval to the preceding 
QT interval (1.20 + 0.15 for type 1, 1.42 _ 0.2.5 for type 2, p = 
0.005) and the mean ratio of the coupling interval to the 
duration of the preceding cycle (0.65 + 0.12 for type 1, 0.77 _+ 
0.20 for type 2, p = 0.04). 
Programmed stimulation. Only three patients had a bal- 
anced distribution of both types of onset, and five had unclas- 
sifiable events. In other words, most patients had either one or 
the other type of ventricular tachycardia nd could therefore 
be grouped accordingly as group 1 (n = 14 with type 1 events) 
or group 2 (n = 37 with type 2 events). Thus, there were fewer 
group 1 patients (14 [24%] of 59) than group 2 patients (63%, 
p < 0.0001). The patients in these two groups tended to have 
different responses to programmed stimulation. Sustained 
monomorphic ventricular tachycardia could be induced in each 
of the group 1 patients and could be terminated by pro- 
grammed stimulation in most patients (two required direct 
current shock, and in two others ventricular tachycardia ended 
spontaneously). In six of the group 1 patients (43%), the 
induced arrhythmia was dissimilar to the spontaneous arrhyth- 
mia. Thus, in some patients with type 1 tachycardia, the 
spontaneous rhythm may have had a different origin than the 
induced tachycardia. 
Most of the 51 classifiable patients (73%) had type 2 
ventricular tachycardia events exclusively (n -- 35) or predom- 
inantly (2 had >300 ventricular tachycardia episodes, but <-2 
events were type 1 in each). The results of programmed 
stimulation in this group were heterogeneous. In seven group 
2 patients (19%), no sustained ventricular arrhythmia could be 
induced espite the aggressive stimulation protocol used in the 
clinical trial. In 18 other patients, the induced arrhythmia was 
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dissimilar to the spontaneous, ustained ventricular tachyar- 
rhythmia. In only 12 group 2 patients [32%) could the spon- 
taneous and induced arrhythmias be classified as possibly 
similar. 
Another distinction between the two groups was that induc- 
tion of ventricular tachycardia tended to require more aggres- 
sive stimulation i  group 2 patients. After exclusion of patients 
in whom tachycardia was not inducible, the mean level of 
stimulation was 3.4 +, 1.5 in group 1 compared with 4.7 +__ 1.8 
in group 2 (p = 0.031); the mean number of ventricular 
extrastimuli required was 1.6 +, 0.5 in group 1 and 2.0 _+ 0.6 in 
group 2 (p = 0.067); and the mean cycle length of the train of 
eight stimuli preceding the extrastimuli was 593 +, 83 ms in 
group 1 compared with 534 _ 90 ms in group 2 (p = 0.045). 
The trend for more vigorous timulation programs persistt:d 
when the analysis was restricted to the 8 group 1 and 11 group 
2 patients in whom induced tachycardia was possibly similar to 
spontaneous ventricular tachycardia. None of the group 1 
patients required more than two extrastimuli to induce ven- 
tricular tachycardia, nd ~one required a basic cycle length 
<600 ms, whereas in the corresponding set of group 2 patients, 
18% required three extrastimuli and 36% required a basic 
cycle length of -<500 ms. 
Outcome. A drug that met efficacy criteria by one of the 
two methods was identified in 8 of the 12 enro!led group 1 
patients. There were no significant differences in the cumula- 
tive probabilities of freedom from arrhythmia recurrences in
the group 1 patients whose treatment was guided by Holter 
monitoring (50 -4- 25% by 1 year with no subsequent events) 
compared with those whose therapy was selected by electro- 
physiologic study (100% and 33 - 27% at 1 and 2 years, 
respectively, p = 0.717). No group 1 patient died during any 
therapy prediced to be effective. 
Among the 26 randomized group 2 patients, 14 were 
assigned to the Holter monitoring limb, and a drug was 
predicted effective in 10 of these (71%). Twelve of the group 2 
patients were assigned to electrophysiologic study, but a drug 
that suppressed induction of ventricular tachycardia was iden- 
tified in only seven (58%). The cumulative probability of 
freedom from arrhythmia recurrences in group 2 patients 
receiving therapy guided by Holter monitoring was signifi- 
cantly greater (100% and 80 _+ 18% at 1 and 2 years, 
respectively, with no additional events by 4 years) than in those 
assigned to electrophysiologic study (43 +_ 19% and 21 -+ 18%, 
at 1 and 2 years: respectively; 0% arrhythmic event free by 
2.2 y, p = 0.001) (Fig. 2). There was only one death (not 
sudden) among group 2 patients receiving antiarrl~ythmic 
therapy selected by Holter monitoring, and this occurred late, 
at 4.3 years (cumulative survival of 67 +_ 27%; survival free of 
sudden death was 100%). In striking contrast, of group 2 
patients treated with a drug selected by electrophy.~iologic 
study, all deaths were sudden, so freedom from both sudden 
and all-cause deaths plummeted to 83 - 15% at 1 year, 42 _ 
30% at 2 years and 0% at 2.2 years (p -< 0.01). 
Clinical characteristics. There were no significant differ- 
ences between groups 1 and 2 with respect o age, gender, 
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Figure 2. Kaplan-Nleier plot indicating cumulative probability of 
remaining free of arrhythmia recurrence in group 2patients discharged 
with medical therapy predicted tobe effective by Holter monitoring 
(n = 10) or by electrophysiologic testing (n = 7). The difference in 
arrhythmic eveut-frce survival was significant (p = 0.001) by the 
log-rank test. 
underlying heart disease, number of myocardial infarctions, 
number of years since last infarction, presence of angina, 
ejection fraction or premature ventricular complex frequency 
(Table 1), nor were there differences inthe use of potentially 
proarrhythmic or antiarrhythmic medications, including digi- 
talis compou~ds, verapamil, diltiazem or beta-blockers. How- 
ever, more group l patients presented with ventricular fibril- 
lation or sudden death and more had class 3 or 4 symptoms of 
heart failure. No clinical characteristics that could account for 
the differences in arrhythmia recurrence aud mortality ob- 
served among roup 2 patients were identified. Specifically, left 
ventricular ejection fraction and heart failure functional class 
in Holter-guided group 2 patients (37 ± 5% and 2.0 +-- 0.2%, 
respectively) did not differ significantly from group 2 patients 
in the electrophysiologic study limb (35 _+ 6% and 2.0 + 0.2%, 
p = 0.85 and p = 0.95, respectively). 
Comparison with patients without spontaneous ventricular 
tachycardia. No clinical features clearly distinguished patients 
with recorded spontaneous ventricular tachycardia from the 
440 patients without recorded spontaneous ventricular tachy- 
cardia who were enrolled in the ESVEM trial (Table 1). 
Patients with recorded ventricular tachycardia had a shorter 
mean time since the last myocardial infarction compared with 
the larger group (5.9 --- 6.8 vs. 8.3 - 8.3 years), and a smaller 
percentage of patients with spontaneous ventricular tachycar- 
dia presented with ventricular fibrillation or sudden death 
(11% vs. 22%), but the statistical significance of these differ- 
ences was marginal (p = 0.049 and p = 0.051, respectively). 
Actuarial analyses also revealed no discernible differences 
in patients wi~h and without spontaneous ventricular tachycar- 
dia. The cumulative probabilities of freedom from arrhythmia 
recurrences at1, 2 and 4 years in the patients with spontaneous 
tachycardia treated with a drug predicted to be effective were 
73 --- 8%, 58 +- 9% and 41 +- 11%, respectively, compared with 
61 + 3%, 50 -+ 4% and 33 + 4%, respectively, in patients 
without spontaneous ventricular tachycardia (p= 0.358). Total 
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Table l. Clinical Characteristics of Patients With and Without Recorded Spontaneous Ventricular Tachycardia 
Group 1 Group 2 All SpVT No SpVT 
(n = 14) (n = 37) p Value* (n = 59) (n = 440) p Valuer 
Age (yr) 64.3 +- 9.7 63.9 z 11.2 0.76 64.5 ± 10.3 64.5 ± 9.7 0.99 
Women 4 (29) 5 (14) 0.23 9 (15) 55 (13) 0.56 
Presenting event 
VF or sudden death 4 (29) 2 (5) , 0.031 7 (11) 98 (22) 0.051 
VT or syncope 10 (71) 35 (95) 52 (88) 342 (78) 0.066 
lsehemic heart disease 13 (93) 27 (73) 0.095 47 (80) 373 (85) 0.37 
Time since last MI (yr) 5.4 ± 9.0 (1.7) 6.1 ± 5.9 (5.0) 0.36 5.9 ± 6.8 (2.5) 8.3 ± 8.3 (6.3) 0.049 
SAS cla~ 3 or 4 8 (57) 6 (16) 0.005 16 (27) 134 (31) 0.59 
Ejection fraction (%) 32 ± 4 37 ± 3 0.29 35 ± 2 32 -+ 1 0.11 
PVC/h on Holter monitoring 320 - 499 (179) 322 __- 439 (134) 0.14 371 - 505 (151) 304 ± 19 0.20 
Digitalis 4 (33) 8 (31) 0.87 14 (30) 165 (38) 0.34 
~¢erapamil or diltiazem 1 (8) 3 (12) 0.76 6 (13) 63 (14) 0.81 
Beta-blocker 2 (17) 3 (12) 0.67 5 (11) 59 (13) 0.62 
*Group 1 (patients with onset of type 1 spontaneous sustained monomorphie ventricular tachyeardia [SpVT]) versus Group 2 (patients with onset of type 2 
ventricular tachycardia [VTi). iPatients with versus without spontaneous ventric'Aar tachyeardia. Data presented are mean value ± SD (median) or number (%) of 
patients and reflect missing data for some variables. MI = myocardial infarction; PVC = premature ventricular cemplexes; SAS = symptomatic a tivity scale; VF = 
ventrieular fihriUation. 
survival in the group with spontaneous ventricular tachycardia 
at 1, 2 and 4 years was 96 _ 4%, 87 +__ 7% and 66 _+ 15% 
compared with 87 - 2%, 81 +_ 3% and 74 _+ 4%, respectively, 
in the group without his arrhythmia (p = 0.896). 
Discussion 
Comparison with previous tudies. The present investiga- 
tion differs from earlier studies in several important ways. Most 
reports of spontaneous sustained taehyarrhythmias consist of 
retrospective accounts of recordings collected uring routine 
clinical practice (27,36-39). In such circumstances the decision 
to perform telemetry or Holter monitoring and the total duration 
of monitoring may have affected the type of patients and arrhyth- 
mias that were collected. In many series of spontaneous arrhyth- 
mias the patients were receiving antiarrhythmie drugs that could 
have altered the initiation of spontaneous ventricular arrhythmias 
and caused arrhythmias that might not otherwise have occurred. 
We are aware of only two studies in which the onset of sponta- 
neous arrhythmias was compared ~,, the results of programmed 
stimulation. In one report he .... nulation protocol varied and 
there were only eight subjects with each type of ventricular 
tachycardia (27). The other study has not been fully published and 
neither the stimulation protocol nor the methods used to com- 
pare spontaneous and induced arrhythmias were stated (40). The 
recordings in this investigation were obtained according to a 
uniform protocol in the course of a clinical trial, along with 
electrophysiologie studies and other prospectively collected ata. 
The subjects were recruited at 14 centers, which should have 
reduced selection bias due to local practice idiosyncrasies. QRS 
waveforms were compared using a quantitative method with 
prespecified cut points, in contrast to previous tudies in which 
comparisons were by subjective visual inspection. Furthermore, 
all episodes of ventricular taehycardia that occurred uring the 
24-h recording period were analyzed. These features may have 
improved the objectivity and reliability of our observaticns. 
Nevertheless, there is rough agreement onthe high prevalence 
of type 2 ventricular tachycardia with previous reports. Akhtar et 
al. (40) found this pattern in 22 (88%) of 25 patients with 
recorded spontaneous ventrieular taehyeardia, and Berger et al. 
(27) detected it in 50% of their 16 patients. Roeike et al. (39) 
identified type 2 onset in 35 (48%) of 73 episodes of ventricular 
tachycardia in 22 patients with implanted cardioverter- 
defibrillators on the basis of electrograms from an intracardiac 
lead. Bardy and Olson (41) observed this pattern in 50% of the 
episodes of ventricular tachycardia n 12 patients with cardiac 
arrest or hemodynamically unstable ventricular tachyarrhythmias. 
Mechanism of type 2 sustained monomorphic ventricular 
tachycardia. In previous tudies, the mechanism of type 2 ven- 
trieular tachycardia was assumed to be rectory (27,39,40). It was 
proposed that the late onset of the initial complex and its 
configurational similarity with subsequent ventricular taehycardia 
beats resulted from concealed, ecremental, s ow conduction of 
sinus impulses within the reentrant circuit (27). According to this 
hypothesis, sinus impulses are conducted with progressive d lay in 
damaged tissue until an area that had been refractory to earlier 
penetration recovers sufficient excitability oallow reentry. Thus, 
the first ventricular complex arises late because the original sinus 
impulse traverses the recntrant path before merging as the initial 
beat of ventrieular tachycardia. An analogous rhythm disturbance 
is the so-called permanent junctional reciprocating tachycardia, 
which is initiated by factors that alter propagation through the 
slowly conducting retrograde limb of if.; ~eentrant circuit, in- 
eluding slight changes in the sinus cycle length and premature 
beats (42). By analogy, if deeremental conduction of sinus beats 
initiates type 2 ventricular tachycardia, then premature beats 
would be likely to produce qual or greater conduction delay and 
would be expected toinitiate type 1 ventricular taehycardia in the 
same circuit. 
Instead, type 1 and type 2 ventricular tacllycardia events 
clearly segregated patients into two groups. Only three patients 
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with more than one episode of ventricular tachycardia of the 
same configuration clearly had both type 1 and type 2 patterns 
associated with the onset of ventricular tachycardia. Of 922 
episodes of ventricular tachycardia n 18 patients with more 
than one type 2 event, only three events had a type 1 pattern 
despite many opportunities for initiation by premature v ntric- 
ular complex (>160,000 premature ventricular complexes). 
The finding that ype 2 events were rarely accompanied bytype 
1 episodes suggests hat type 2 ventricular tachycardia does not 
always result from uncomplicated reentry. 
Programmed stimulation. The results of electrophysiologic 
studies also did not support he idea that type 2 ventricular 
taehycardia results from reentry of sinus impulses. Sustained 
monomorphic ventricular tachycardia could not be reduced in 
7 group 2 patients (19%), and in 18 others (49%) the induced 
arrhythmia did not resemble the spontaneous arrhythmia. In
these 18 patients it was not possible to determine whether the 
spontaneous arrhythmia was not reproduced because another 
sustained arrhythmia was more easily induced or because the 
spontaneous arrhythmia was not inducible. In addition, the 
arrhythmias that were induced in group 2 patients required 
more aggressive stimulation programs that were required for 
group 1 patients. Thus, the pattern of spontaneous onset and 
response to programmed stimulation in patients with type 1 
ventri~ular tachycardia were consistent with reentry (5), 
whereas the patterns observed in group 2 patients uggest 
nonreentrant mechanisms orforms of reentry that do not have 
the classic response to programmed stimulation. 
Outcome. Group 1 and group 2 patients also appeared to be 
distinguished by their responses to the management approach, 
but because of the small number of patients discharged on 
assigned therapy, no conclusions about outcome could be made. 
Nevertheless, the patients were randomized to a treatment limb 
and the observed differences did achieve statistical significance, so
the results are of interest considering the different arrhythmia 
patterns in the two groups. The response of group 2 patients to 
Holter-guided therapy was remarkably good with a probability of 
arrhythmia recurrence of only 20 __. 18% at 4 years and no deaths 
by that time. Possibly, the requirement of substantial reductions 
of single, pairs and runs of ventricular complexes (70%, 80% ~.nd 
90%, respectively) and total elimination of all runs ->15 ventric- 
ular complexes (14) provided satisfactory control. In contrast, 
group 2 patients treated with antiarrhythmic drugs selected by 
electrophysiologic study did poorly (cumulative probability of 
arrhythmia recurrence and sudden death of 100% by 2.2 years). 
The reason that suppression of inducible ventricular tachycardia 
was ineffective in these patients is unclear, but it is plausible that 
the rhythms uppressed by the antiarrhythmic drugs were clini- 
cally irrelevant and misled drug selection. 
Stud), limitations. The patients in the present study were a 
highly select group, and our findings cannot be assumed to 
apply to all patients with sustained ventricular tachyarrhyth- 
raias. The fact that they underwent ambulatory monitoring in 
the absence of antiarrhythmie drugs eliminated subjects whose 
initial arrhythmias were fatal and those with frequent heron- 
dynamically unstable arrhythmias that required continuous 
suppression. The fact that a sustained arrhythmia occurred 
during monitoring favored patients with frequent arrhythmias. 
By contrast, several features of this investigation could 
enhance the reliability of the findings. The patients were 
referred for treatment of symptomatic ventricular tachy- 
arrhythmias and therefore constitute a group of therapeutic 
interest. A spectrum 3f arrhythmias was observed from well 
tolerated tachycardia to rapid rhythms that degenerated into 
ventricular fibrillation and required direct current shock. 
Moreover, the patients with recorded ventricular tachycardia 
comprised ~10% of the patients enrolled in the ESVEM trial, 
and no clinical characteristics clearly differentiated the patients 
with spontaneous arrhythmias. Therefore, although selection 
biases may have existed in the sample, some of the findings 
probably apply to othei patients with recurrent ventricular 
tachyarrhythmias. Indeed, it would be surprising if the under- 
lying principles of arrhythmogenesis demonstrated in the pa- 
tients tudied iffer fundamentally from those in other patients 
with recurrent ventricular tachycardia. 
Theoretic and clinical implications. Because premature 
beats were not required for the initiation of ventricular tachy- 
cardia in this investigation, this does not prove or exclude the 
presence of a particular arrhythmia mechanism (25,26). Fur- 
thermore, the failure to induce ventricular tachycardia with 
programmed stimuli does not exclude reentry as a mechanism 
of the spontaneous arrhyth"aias, because a particular site of 
stimulation or other factors not reproduced at electrophysi- 
oiogic study may be necessary to initiate tachycardia. Thus, any 
of the three major categories of arrhythmia mechanisms-- 
reentry, triggered activity and automaticity--could be respon- 
sible for the observed arrhythmias. Nevertheless, the findings at 
least suggest that mechanisms other than classically conceived 
reentry could be responsible for ti:.e majority of spontaneous 
ventficular tachyarrhythmias examined in the present study. 
These findings could have clinical consequences. If a sub- 
stantial fraction of a population behave as group 2 patients 
with a significantly better outcome with therapy selected by 
Holter monitoring and a worse outcome with therapy identi- 
fied by electrophysiologic study, the overall results would shift 
in favor of Hoiter monitoring. This might account for some of 
the differences between studies (17-20). 
Conclusions. Reentry is widely believed to be the mecha- 
nism of ventricular tachycardia because of the reproducible 
initiation and termination by programmed stimulation (5,7,8), 
the response to electrical stimuli during tachycardia (43,44), 
the effects of drugs (6) and the electrical activation sequence 
(45). However, the classic paradigm of arrhythmogenesis, in 
which piemature ventricular complex activates a stable sub- 
strate for reentry, could not readily accot, nt for the properties 
of spontaneous arrhythmias most commonly observed in this 
group of patients. In addition, the pattern of initiation of 
spontaneous ventricular tachycardia may distinguish patients 
with different responses to programmed stimulation and treat- 
ment. These findings, in combination with the high rates of 
sudden death and arrhythmia recurrences observed in recent 
trials despite the use of accepted modes of therapy (11-13,16) 
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and the inability to predict and prevent proarrhythmic events, 
indicate that current models of arrhythmogenesis are seriously 
flawed. Quite possibly, the fact that inducible reentrant ven- 
trieular arrhythmias re the most readily accessible for inves- 
tigation has resulted in their being overemphasized as the 
mechanism of clinical arrhythmias. Our results suggest that 
greater emphasis should be placed on the capture and analysis 
of spontaneous arrhythmias so that their properties may be 
incorporated into more representative and comprehensive 
models of arrhythmogenesis, which will provide better predic- 
tion and treatment of life4hreatening arrhythmias. 
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